Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 CRF01-AE integrase derived from drug-naive thai patients

AIDS Research and Human Retroviruses

Volumn 26, Issue 12, 2010, Pages 1341-1343

  Isarangkura Na Ayuthaya, Panasda ^a   Kaewnoo, Wiyada ^a   Auwanit, Wattana ^a   De Silva, U Chandimal ^b,c   Ikuta, Kazuyoshi ^b,c   Sawanpanyalert, Pathom ^a   Kameoka, Masanori ^b,c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b Thailand Japan Research Collaboration Center on Emerging and Re emerging Infections RCC ERI   (Thailand)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [5 (4 FLUOROBENZYL) 2 FURYL] 3 (1,2,4 TRIAZOL 3 YL) 1,3 PROPANEDIONE; INTEGRASE; INTEGRASE INHIBITOR; L 187810; L 708906; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; GENE SEQUENCE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; THAILAND; VIRUS MUTATION; VIRUS TYPING;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV INTEGRASE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PLASMA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; THAILAND;

EID: 78650277555     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0140     Document Type: Article

References (15)

1. Johnson VA, Brun-Vezinet F, Clotet B, et al.: Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med 2009;17:138-145.
2. Ramkumar K, Serrao E, Odde S, and Neamati N: HIV-1 integrase inhibitors: 2007-2008 update. Med Res Rev 2010 [DOI 10.1002/med.20194].
3. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global and regional distribution of HIV-1 genetic subtypes and recom-binants in 2004. AIDS 2006;20:W13-23.
4. Myers RE and Pillay D: Analysis of natural sequence vari-ation and covariation in human immunodeficiency virus type 1 integrase. J Virol 2008;82:9228-9235.
5. Canducci F, Marinozzi MC, Sampaolo M, et al.: Genotypic/phenotypic patterns of HIV-1 integrase resistance to ralte-gravir. J Antimicrob Chemother 2010;65:425-433.
6. Shimura K, Kodama E, Sakagami Y, et al.: Broad anti-retroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol 2008;82:764-774.
7. Hazuda DJ, Anthony NJ, Gomez RP, et al.: A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 in-tegrase. Proc Natl Acad Sci USA 2004;101:11233-11238.
8. Fikkert V, Van Maele B, Vercammen J, et al.: Development of resistance against diketo derivatives of human immunode-ficiency virus type 1 by progressive accumulation of in-tegrase mutations. J Virol 2003;77:11459-11470.
9. Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, and Perno CF: Characterization and structural analysis of HIV-1 integrase conservation. AIDS Rev 2009; 11:17-29.
10. Cooper DA, Steigbigel RT, Gatell JM, et al.: Subgroup and resistance analyses of raltegravir for resistant HIV-1 infec-tion. N Engl J Med 2008;359:355-365.
11. Arruda LB, Fonseca LA, Duarte AJ, and Casseb J: Genetic di-versity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in Sao Paulo City, Brazil. AIDS Res Hum Retroviruses 2010;26:105-107.
12. Low A, Prada N, Topper M, et al.: Natural polymorphisms of human immunodeficiency virus type 1 integrase and in-herent susceptibilities to a panel of integrase inhibitors. Antimicrob Agents Chemother 2009;53:4275-4282.
13. Eshleman SH, Hudelson SE, Smith P, et al.: Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. AIDS Res Hum Retroviruses 2009;25:343-345.
14. Van Laethem K, Schrooten Y, Covens K, et al.: A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes. J Virol Methods 2008;153: 176-181.
15. Rhee SY, Liu TF, Kiuchi M, et al.: Natural variation of HIV-1 group M integrase: Implications for a new class of anti-retroviral inhibitors. Retrovirology 2008;5:74.